EZH2 and diffuse large B-cell lymphoma: Therefore, inhibition of HDAC1,2 activity alone or in combination with inhibition of EZH2 activity could be an alternative strategy to overcome lymphomagenesis in DLBCL cells by blocking the gain-of-function mutant EZH2 mediated H3K27 hypertrimethylation via increased histone acetylation.